None (Healthy adults)
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Females aged from 20 to less than 30 years old, when giving the informed consent. 2) Females with consistent severity of symptoms of premenstrual syndrome (PMS). 3) Individuals who give the informed consents in writing, after receiving enough explanation of the purpose and details of the study, understanding the study well, and deciding to attend the study with their own will.
Exclusion criteria
Exclusion criteria: 1) Individuals who receives medications or functional foods affecting on the female hormone. 2) Individuals whose menstrual cycle is more than 18 days, less than 45 days, or extremely fluctuating. 3) Individuals who are pregnant, planning to be pregnant, or breastfeeding during the test period. 4) Individuals who are or have been serious metabolic disease, including diabetes, thyroid disease, and adrenal disease. 5) Individuals whose body mass index (BMI) is lower than 18.5 kg/m-2, or higher than 32 kg/m-2. 6) Individuals who are drug fiend or alcoholic. Individuals who have a history of drug fiend or alcoholic. 7) Individuals who have smoking habitat. 8) Individuals who are going to be abroad for a long period and are difficult to participate to the study for at least one menstrual cycle. 9) Individuals who are participating or willing to participate in another clinical trial with intervention of foods, medications, and cosmetics. 10) Individuals who work for the company developing, producing, or selling functional foods. 11) Individuals who are judged unsuitable for this study by the investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of the biogas depending on the menstrual cycle from skin surface using GC-MS. | — |
Countries
Japan
Contacts
Nara Women's University Faculty of Human Life and Environmental Health